Pages that link to "Q48225200"

The following pages link to Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands (Q48225200):

Displaying 24 items.

• Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population (Q33685609) (← links)
• High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany (Q33836050) (← links)
• Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. (Q33867667) (← links)
• Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. (Q34349806) (← links)
• Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2 (Q34358301) (← links)
• Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2. (Q35078193) (← links)
• Treatment in myotonia and periodic paralysis (Q35843236) (← links)
• Myotonic dystrophy type 2 and related myotonic disorders (Q35926958) (← links)
• Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia (Q36979268) (← links)
• Premutation allele pool in myotonic dystrophy type 2. (Q37180513) (← links)
• Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2. (Q37440074) (← links)
• Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies (Q38209927) (← links)
• Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism (Q39012035) (← links)
• Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families. (Q42638792) (← links)
• Pain in patients with myotonic dystrophy type 2: a postal survey in Finland (Q43860848) (← links)
• Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes (Q47929916) (← links)
• Muscle biopsy. (Q48242777) (← links)
• Tau, a biological marker of neurodegenerative diseases (Q49077237) (← links)
• Early onset posterior subscapular cataract in a series of myotonic dystrophy type 2 patients (Q50006110) (← links)
• Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies. (Q55645755) (← links)
• Proximal myotonic dystrophy mimicking progressive muscular atrophy (Q57085823) (← links)
• Myotonic dystrophy type 2 is rare in the Japanese population (Q58036207) (← links)
• Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2. (Q64917809) (← links)
• Consensus-based care recommendations for adults with myotonic dystrophy type 2 (Q90471051) (← links)